Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohong Liu

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Molecular Pharmacology|April 23, 2004
Cav1.3 is preferentially coupled to glucose-induced [Ca2+]i oscillations in the pancreatic beta cell line INS-1Guohong Liu, Nathan Hilliard, Gregory H Hockerman
Current Pharmaceutical Biotechnology|July 12, 2011
Fusogenic oncolytic herpes simplex viruses as a potent and personalized cancer vaccineQi-Xiang Li, Guohong Liu, Xiaoliu Zhang
Frontiers in Pharmacology|March 20, 2019
Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell CarcinomaYunbao Pan, Guohong Liu, Dujuan Wang, et al.
Genes & Diseases|February 11, 2021
Immune checkpoint: The novel target for antitumor therapyXianghu Jiang, Guohong Liu, Yirong Li, et al.
Future Oncology (London, England)|April 7, 2020
lncRNA and mRNA signature for prognosis prediction of glioblastomaGuohong Liu, Yunbao Pan, Yueying Li, et al.
Frontiers in Pharmacology|February 12, 2021
Potential of Immune-Related Therapy in COVID-19Chunjue Yuan, Ruoyun Li, Guohong Liu, et al.
Medical Oncology (Northwood, London, England)|March 9, 2013
Clinical implications of CIP2A protein expression in breast cancerGuangzhe Yu, Guohong Liu, Juan Dong, et al.
Environmental Research|May 11, 2026
Exploring the adsorption and sensing properties of multiscale COFs toward PFAS: Effects of pore size, chain length, and functional groupsYuanchao Li, Ning Liu, Guohong Liu, et al.
Genes & Diseases|July 3, 2023
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategiesLiping Wang, Zhe Chen, Guohong Liu, et al.
International Journal of Clinical Oncology|May 21, 2021
Jab1/Cops5: a promising target for cancer diagnosis and therapyChunjue Yuan, Dong Wang, Guohong Liu, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Molecular Pharmacology|April 23, 2004
Cav1.3 is preferentially coupled to glucose-induced [Ca2+]i oscillations in the pancreatic beta cell line INS-1Guohong Liu, Nathan Hilliard, Gregory H Hockerman
Current Pharmaceutical Biotechnology|July 12, 2011
Fusogenic oncolytic herpes simplex viruses as a potent and personalized cancer vaccineQi-Xiang Li, Guohong Liu, Xiaoliu Zhang
Frontiers in Pharmacology|March 20, 2019
Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell CarcinomaYunbao Pan, Guohong Liu, Dujuan Wang, et al.
Genes & Diseases|February 11, 2021
Immune checkpoint: The novel target for antitumor therapyXianghu Jiang, Guohong Liu, Yirong Li, et al.
Future Oncology (London, England)|April 7, 2020
lncRNA and mRNA signature for prognosis prediction of glioblastomaGuohong Liu, Yunbao Pan, Yueying Li, et al.
Frontiers in Pharmacology|February 12, 2021
Potential of Immune-Related Therapy in COVID-19Chunjue Yuan, Ruoyun Li, Guohong Liu, et al.
Medical Oncology (Northwood, London, England)|March 9, 2013
Clinical implications of CIP2A protein expression in breast cancerGuangzhe Yu, Guohong Liu, Juan Dong, et al.
Environmental Research|May 11, 2026
Exploring the adsorption and sensing properties of multiscale COFs toward PFAS: Effects of pore size, chain length, and functional groupsYuanchao Li, Ning Liu, Guohong Liu, et al.
Genes & Diseases|July 3, 2023
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategiesLiping Wang, Zhe Chen, Guohong Liu, et al.
International Journal of Clinical Oncology|May 21, 2021
Jab1/Cops5: a promising target for cancer diagnosis and therapyChunjue Yuan, Dong Wang, Guohong Liu, et al.
Pageof 18